Editas Medicine Inc (EDIT)
2.865
-0.04
(-1.55%)
USD |
NASDAQ |
Nov 04, 16:00
2.88
+0.02
(+0.52%)
After-Hours: 20:00
Editas Medicine Market Cap: 236.29M for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 240.01M |
| October 31, 2024 | 239.18M |
| October 30, 2024 | 249.08M |
| October 29, 2024 | 256.50M |
| October 28, 2024 | 268.87M |
| October 25, 2024 | 262.28M |
| October 24, 2024 | 262.28M |
| October 23, 2024 | 264.75M |
| October 22, 2024 | 271.35M |
| October 21, 2024 | 310.11M |
| October 18, 2024 | 277.12M |
| October 17, 2024 | 273.00M |
| October 16, 2024 | 284.54M |
| October 15, 2024 | 277.12M |
| October 14, 2024 | 267.22M |
| October 11, 2024 | 263.10M |
| October 10, 2024 | 244.13M |
| October 09, 2024 | 257.33M |
| October 08, 2024 | 261.45M |
| October 07, 2024 | 264.75M |
| October 04, 2024 | 278.77M |
| October 03, 2024 | 263.92M |
| October 02, 2024 | 265.57M |
| October 01, 2024 | 269.70M |
| September 30, 2024 | 281.24M |
| Date | Value |
|---|---|
| September 27, 2024 | 287.02M |
| September 26, 2024 | 287.84M |
| September 25, 2024 | 279.60M |
| September 24, 2024 | 291.14M |
| September 23, 2024 | 301.86M |
| September 20, 2024 | 310.94M |
| September 19, 2024 | 322.48M |
| September 18, 2024 | 320.01M |
| September 17, 2024 | 318.36M |
| September 16, 2024 | 315.88M |
| September 13, 2024 | 325.78M |
| September 12, 2024 | 309.29M |
| September 11, 2024 | 311.76M |
| September 10, 2024 | 310.94M |
| September 09, 2024 | 289.49M |
| September 06, 2024 | 296.09M |
| September 05, 2024 | 287.84M |
| September 04, 2024 | 288.67M |
| September 03, 2024 | 287.84M |
| August 30, 2024 | 308.46M |
| August 29, 2024 | 305.99M |
| August 28, 2024 | 303.51M |
| August 27, 2024 | 315.06M |
| August 26, 2024 | 323.31M |
| August 23, 2024 | 319.18M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
236.29M
Minimum
Nov 04 2024
5.667B
Maximum
Jan 08 2021
1.446B
Average
1.080B
Median
Market Cap Benchmarks
| EyePoint Pharmaceuticals Inc | 625.63M |
| Cassava Sciences Inc | 1.241B |
| Regeneron Pharmaceuticals Inc | 91.08B |
| Vertex Pharmaceuticals Inc | 122.14B |
| Adverum Biotechnologies Inc | 156.63M |
Market Cap Related Metrics
| PS Ratio | 3.501 |
| Price to Book Value | 1.019 |
| Price | 2.865 |
| Earnings Yield | -82.37% |